Antagonism of the renin-angiotensin-aldosterone system and collagen metabolism in cardiac fibroblasts

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 21, Issue 3, 1999, Pages 215-227

  Lijnen, Paul ^a,b   Petrov, Victor ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Aldosterone; Angiotensin; Collagen; Fibroblasts; Renin

Indexed keywords

1 (4 AMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDROIMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CANDESARTAN HEXETIL; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL; LOSARTAN; PERINDOPRIL; SAPRISARTAN;

ANIMAL CELL; ANIMAL MODEL; ANTIHYPERTENSIVE THERAPY; COLLAGEN SYNTHESIS; DRUG EFFECT; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; NONHUMAN; ORAL DRUG ADMINISTRATION; OSMOTIC MINIPUMP; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SPONTANEOUSLY HYPERTENSIVE RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; COLLAGEN; CRICETINAE; FIBROBLASTS; HUMANS; MYOCARDIUM; RATS; RENIN-ANGIOTENSIN SYSTEM;

EID: 0032980016     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.1999.21.3.534832     Document Type: Review

References (134)

1. Dzau, V.J. Tissue renin-angiotensin system: Physiologic and pharmacologic implications: Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 1988, 77: 11-13.
2. Baker, K.M., Booz, G.W., Dostal, D.E. Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system. Ann Rev Physiol 1992, 54: 227-41.
3. Weber, K.T., Brilla, C.G. Pathological hypertrophy and cardiac interstitium: Fibrosis and the renin-angiotensin-aldosterone system. Circulation 1991, 83: 1849-65.
4. Jalil, J.E., Dowering, C.W., Janicki, J.S., Pick, R., Clark, W.A., Weber, K.T. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 1989, 64: 1041-50.
5. Anversa, P., Olivetti, G., Melissari, M., Loud, A.V. Morphometric study of myocardial hypertrophy induced by abdominal aortic stenosis. Lab Invest 1979, 40: 341-9.
6. Weber, K.T., Clark, W.A., Janicki, J.S., Schroff, S.G. Physiologic versus pathologic hypertrophy and the pressure overload myocardium. J Cardiovasc Pharmacol 1987, 10: S32-49.
7. Lindpaintner, K., Ganten, D. The cardiac renin-angiotensin system. Appraisal of present experimental and clinical evidence. Circ Res 1991, 68: 905-21.
8. Sadoshima, J., Xu, Y., Slayter, H.S., Izumo, S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993, 75: 977-84.
9. 1 receptor subtype. Circ Res 1993, 73: 413-23.
10. Sun, Y., Weber, K.T. Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J Mol Cell Cardiol 1996, 28: 851-8.
11. Yoshida, K., Kohzuki, M., Casley, D.J., Johnston, C.I. Angiotensin-converting enzyme inhibition and salt in experimental myocardial infarction. J Cardiovasc Pharmacol 1998, 32: 357-65.
12. Sun, Y., Weber, K.T. Angiotensin II receptor binding following myocardial infarction in the rat. Cardiovasc Res 1994, 28: 1623-8.
13. Katwa, L.C., Campbell, S.E., Tyagi, S.C., Lee, S.J., Cicila, G.T., Weber, K.T. Cultured myofibroblasts generate angiotensin peptides de novo. J Mol Cell Cardiol 1997, 29: 1375-86.
14. Lindpaintner, K., Lee, M.A., Larson, M.G., Rao, S., Pfeffer, M.A., Ordovas, J.M., Schaefer, E.J., Wilson, A.F., Wilson, P.W.F., Vasan, R.S., Myers, R.H., Levy, D. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med 1996, 334: 1023-8.
15. Abhold, R.H., Sullivan, M.J., Wright, J.W., Harding, J.W. Binding, degradation and pressor activity of angiotensin II and III after aminopeptidase inhibition with amastatin and bestatin. J Pharmacol Exp Ther 1987, 242: 957-62.
16. Ahmad, S., Ward, P.Z. Role of aminopeptidase activity in the regulation of the pressor activity of circulating angiotensins. J Pharmacol Exp Ther 1990, 252: 643-50.
17. Hooper, N.M., Hryszko, J., Oppong, S.Y., Turner, A.J. Inhibition by converting enzyme inhibitors of pig kidney aminopeptidase P. Hypertension 1992, 19: 281-5.
18. Wintroub, B.U., Schechter, N.B., Lazarus, G.S., Kaempfer, C.E., Schwartz, L.B. Angiotensin I conversion by human and rat chymotryptic proteinases. J Invest Dermatol 1984, 83: 336-9.
19. Miller, J.J., Changaris, D.G., Levy, R.S. Conversion of angiotensin I to angiotensin II by cathepsin A isoenzymes of porcine kidney. Biochem Biophys Res Commun 1988, 154: 1122-9.
20. Reilly, C.F., Schechter, N.B., Travis, J. Inactivation of bradykinin and kallidin by cathepsin G and mast cell chymase. Biochem Biophys Res Commun 1985, 127: 443-9.
21. Tonnesen, M.G., Klempner, M.S., Austen, K.F., Wintroub, B.U. Identification of a human neutrophil angiotensin II-generating protease as cathepsin G. J Clin Invest 1982, 69: 25-30.
22. Reilly, C.F., Tewksbury, D.A., Schechter, N.M., Travis, J. Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J Biol Chem 1982, 257: 8619-22.
23. Shiota, N., Fukamizu, A., Takai, S., Okunishi, H., Murakami, K., Miyzaki, M. Activation of angiotensin II-forming chymase in the cardiomyopathic hamster heart. J Hypertens 1997, 15: 431-40.
24. Urata, H., Kinoshita, A., Misono, K.S., Bumpus, F.M., Husain, A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 1990, 265: 22348-57.
25. Husain, A. The chymase-angiotensin system in humans. J Hypertens 1993, 11: 1155-9.
26. Urata, H., Nishimura, H., Ganten, D. Chymase-dependent angiotensin II-forming system in humans. Am J Hypertens 1996, 9: 227-84.
27. Urata, H., Boehm, K.D., Philip, A., Kinoshita, A., Gabrovsek, J., Bumpus, F.M., Husain, A. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest 1993, 91: 1269-81.
28. Studer, R., Reinecke, H., Moller, B., Holtz, J., Just, H., Drexier, H. Increased angiotensin-I converting enzyme gene expression in the failing human heart. J Clin Invest 1994, 94: 301-10.
29. Crabos, M., Roth, M., Hahn, A.W.A., Erne, P. Characterization of angiotensin II receptors in cultured rat cardiac fibroblasts: Coupling to signaling systems and gene expression. J Clin Invest 1994, 93: 2372-8.
30. Villareal, F.J., Kim, N.N., Ungab, G.D., Printz, M.P., Dilmann, W.H. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 1993, 88: 2849-61.
31. Schorb, W., Booz, G.W., Dostal, D.E., Conrad, K.M., Chang, K.C., Baker, K.M. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res 1993, 72: 1245-54.
32. Matsubara, H., Kanasaki, M., Murasawa, S., Tsukuguchi, Y., Nio, Y., Inada, M. Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture. J Clin Invest 1994, 93: 1592-1601.
33. Brilla, C.G., Zhou, G., Matsubara, L., Weber, K.T. Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994, 26: 809-20.
34. Gallagher, A.M., Bahnson, T.D., Yu, H., Kim, N.N., Printz, M.P. Species variability in angiotensin receptor expression by cultured cardiac fibroblasts and the infarcted heart. Am J Physiol 1998, 274: H801-9.
35. Booz, G.W., Baker, K.M. Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts. Cardiovasc Res 1995, 30: 537-43.
36. phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts. Hypertension 1998, 32: 331-7.
37. Köhler, E., Bertschin, S., Woodtli, T., Resink, T., Erne, P. Does aldosterone-induced cardiac fibrosis involve direct effects on cardiac fibroblasts? J Vasc Res 1996, 33: 315-26.
38. Slight, S., Ganjam, V.K., Nonnemann, D., Weber, K.T. Glucocorticoid metabolism in the cardiac interstitium: IIβ-hydroxysteroid dehydrogenase activity in cardiac fibroblasts. J Lab Clin Med 1993, 122: 180-7.
39. Funder, J.W., Pearce, P.T., Smith, R., Smith, A.I. Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated. Science 1988, 242: 583-5.
40. Meyer, W.J., Nichols, N.R. Mineralocorticoid binding in cultured smooth muscle cells and fibroblasts from rat aorta. J Steroid Biochem 1981, 14: 1157-68.
41. Bonvalet, J.P., Alfaidy, N., Farman, N., Lombès, M. Aldosterone: Intracellular receptors in human heart. Eur Heart J 1995, 16: S92-7.
42. Lombès, M., Alfaidy, N., Eugene, E., Lessana, A., Farman, N., Bonvalet, J.P. Prerequisite for cardiac aldosterone action. Circulation 1995, 92: 175-82.
43. Reul, J.M.H.M., Pearce, P.T., Funder, J.W., Krozowski, Z.S. Type I and type II corticosteroid receptor gene expression in the rat: Effect of adrenalectomy and dexamethasone administration. Mol Endocrinol 1989, 3: 1674-80.
44. Pelouch, V., Dixon, I.H.C., Golfman, L., Beamish, R.E., Dhalla, N.S. Role of extracellular matrix proteins in heart function. Mol Cell Biochem 1994, 129: 101-20.
45. Murakami, M., Kusachi, S., Nakahama, M., Naito, I., Murakami, T., Doi, M., Kondo, J., Higashi, T., Ninomiya, Y., Tsuji, T. Expression of the α1 and α2 chains of type IV collagen in the infarct zone of rat myocardial infarction. J Mol Cell Cardiol 1998, 30: 1191-1202.
46. Burton, A.C. Relation of structure to function of the tissues of the wall of blood vessels. Physiol Rev 1954, 34: 619-42.
47. Weber, K.T., Janicki, J.S., Schroff, S.G., Pick, R., Chen, R.M., Bashey, R.I. Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res 198, 62: 757-65.
48. Jensen, L.T., Høst, N.B. Collagen: Scaffold for repair and execution. Cardiovasc Res 1997, 33: 535-9.
49. Diez, J., Laviades, C. Monitoring fibrillar collagen turnover in hypertensive heart disease. Cardiovasc Res 1997, 35: 202-5.
50. Simedrod, B., Melkko, J., Risteli, L., Risteli, J. Circulating C-terminal propeptide of type I procollagen is cleared mainly via a mannose receptor in the liver endothelial cells. Biochem J 1990, 271: 345-50.
51. Raedsch, R., Stiehl, A., Sieg, A., Walther, S., Kommerell, B. Biliary excretion of procollagen type III peptide in healthy humans and in patients with alcoholic cirrhosis of the liver. Gastroenterology 1983, 85: 1265-70.
52. Risteli, J., Elomaa, I., Niemi, S., Novamo, A., Risteli, L. Radioimmunoassay for the pyridoline cross-linked carboxy-terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation. Clin Chem 1993, 39: 635-40.
53. Weber, K.T., Sun, Y., Katwa, L.C., Cleutjens, J.P.M., Zhou, G. Connective tissue and repair in the heart. Ann NY Acad Sci 1995, 752: 286-99.
54. Weber, K.T., Sun, Y., Katwa, L.C. , Cleutjens, J.P.M. Connective tissue: Metabolic entity? J Mol Cell Biol 1995, 27: 107-20.
55. Whalley, D. Inflammatory and vascular basis of connective tissue disease. In: Pathological Basis of the Connective Tissue Diseases. Gardner, D.I. (Ed.). Lea Febiger: Philadelphia 1992, 282-99.
56. Skalli, O., Schürch, W., Seemayer, T., Lagace, R., Montandon, D., Piftet, B., Gabbiani, G. Myofibroblasts from diverse pathologic settings in their content of actin isoforms and intermediate filament proteins. Lab Invest 1989, 60: 275-85.
57. Sun, Y., Ramirez, F.J.A., Weber, K.T. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. Cardiovasc Res 1977, 35: 138-47.
58. Sun, Y., Ratajska, A., Weber, K.T. Bradykinin receptor and tissue ACE binding in myocardial fibrosis: Response to chronic angiotensin II or aldosterone administration in rats. J Mol Cell Cardiol 1995, 27: 813-22.
59. Piquet, P.F., Grau, G.E., Vassali, P. Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis. Am J Pathol 1990, 136: 103-10.
60. Gabbiani, G., Ryan, G.F., Majno, G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971, 27: 549-50.
61. Sappino, A.P., Schürch, W., Gabbiani, G. Differentiation repertoire of fibroblastic cells: Expression of cytoskeletal proteins as marker of fenotypic modulation. Lab Invest 1990, 63: 144-61.
62. Darby, I., Skalli, O., Gabbiani, G. alpha-Smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990, 63: 21-9.
63. Willems, I.E.M.G., Havenith, M.G., De Mey, J.G.R., Daemen, M.J.A.P. The α-smooth muscle actin-positive cells in healing human myocardial scars. Am J Pathol 1994, 145: 868-75.
64. Vraco, R., Thorning, D. Contractile cells in rat myocardial scar tissue. Lab Invest 1991, 65: 214-27.
65. Gabbiani, G., Majno, G. Dupuytren's contracture: Fibroblast contraction. Am J Pathol 1972, 66: 131-46.
66. Gabbiani, G., Hirschel, B.J., Ryan, C.B., Statkov, P.R., Majno, G. Granulation tissue as a contractile organ. A study of structure and function. J Exp Med 1972, 135: 719-34.
67. Estes, J.M., Vande Bergh, J.S., Adzich, N.S., MacGillivray, T.E., Desmoulière, A., Gabbiani, G. Phenotypic and functional features of myofibroblasts in sheep fetal wounds. Differentiation 1994, 56: 173-81.
68. Desmoulière, A., Geinoz, A., Gabbiani, F., Gabbiani, G. Transforming growth factor β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993, 122: 103-11.
69. Ronnov-Jessen, L., Petersen, O.W. induction of α-smooth muscle actin by transforming growth factor-β1 in quiescent human breast gland neoplasia. Lab Invest 1993, 68: 696-707.
70. Vyalov, S.L., Gabbiani, G., Kapanci, Y. Rat alveolar myofibroblasts acquire α-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis. Am J Pathol 1993, 143: 1754-65.
71. Zhang, K., Rekhter, M.D., Gordon, D., Phan, S.H. Myofibroblasts and their role in lung collagen expression during pulmonary fibrosis: A combined immunohistochemical and in situ hybridization. Am J Pathol 1994, 145: 114-25.
72. 2 on the activation of quiescent lung fibroblasts. Piostaglandins 1997, 33: 903-13.
73. Berg, R.A., Moss, J., Baun, B.J., Crystal, R.G. Regulation of collagen production by the beta-adrenergic system. J Clin Invest 1981, 67: 1457-62.
74. Fine, A., Goldstein, R.H. The effect of transforming growth factor-β on cell proliferation and collagen formation by lung fibrosis. J Biol Chem 1997, 262: 3897-902.
75. Goldstein, R.H., Poliks, C.F., Pilch, P.F., Smith, B.D., Fine, A. Stimulation of collagen formation by insulin and insulin-like growth factor I in cultures of human lung fibroblasts. Endocrinology 1989, 124: 964-70.
76. Brilla, C.G., Scheer, C., Rupp, H. Renin-angiotensin system and myocardial collagen matrix: Modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism. J Hypertens 1997, 15: S13-9.
77. Sano, H., Okada, H., Kawagachi, H., Yasuda, H. Increased angiotensin II-stimulated collagen synthesis in cultured cardiac fibroblasts from spontaneously hypertensive rats. Circulation 1991, 84: II48.
78. 1 in adult rat cardiac fibroblasts. J MoL Cell Cardiol 1995, 27: 2347-57.
79. Fisher, S.A., Absher, M. Norepinephrine and ANG II stimulate secretion of TGF-β by neonatal rat cardiac fibroblasts in vitro. Am J Physiol 1995, 268: C910-7.
80. 1 expression determines growth response to angiotensin II. J Clin Invest 1992, 90: 456-61.
81. 1 in the cellular response to angiotensin II. Hypertension 1993, 21: 1046-50.
82. 1 in cardiac fibroblasts and myofibroblasts. J MoL Cell Cardiol 1997, 29: 1947-58.
83. Lijnen, P., Petrov, V., Fagard, R. Stimulation of collagen secretion by angiotensin Ii and transforming growth factor-β in rat cardiac fibroblasts. Eur Heart J 1998, 19: 488.
84. l. J Am Coll Cardiol 1994, 23: 43A.
85. 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats. J Pharmacol Exp Ther 1995, 273: 509-15.
86. Brilla, C.G., Rupp, H., Funck, R., Maisch, B. The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure. Eur Heart J 1995, 16: S107-9.
87. Mazzolai, L., Nussberger, J., Aubert, J.F., Brunner, D.B., Gabbiani, G., Brunner, H.R., Pedrazzini, T. Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension 1998, 31: 1324-30.
88. Fullerton, M.J., Funder, J.W. Aldosterone and cardiac fibrosis: In vitro studies. Cardiovasc Res 1994, 28: 1863-7.
89. Petrov, V., Fagard, R., Lijnen, P. Effect ofangiotensin II and transforming growth factor-β on collagen secretion in cardiac fibroblasts. Am J Hypertens 1998, 11: 146A.
90. Campbell, S.E., Janicki, J.S., Weber, K.T. Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone. J Mol Cell Cardiol 1995, 27: 1545-60.
91. Tan, L.B., Jalil, J.E., Pick, R., Janicki, J.S., Weber, K.T. Cardiac myocyte necrosis induced by angiotensin II. Circ Res 1991; 69: 1185-95.
92. Crawford, D.C., Chobanian, A.V., Brecher, P. Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ Res 1994, 74: 727-39.
93. Robert, V., Van, T.N., Cheav, S.L., Mouas, C., Swynghedauw, B., Delcayre, C. Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension. Hypertension 1994, 24: 30-6.
94. Young, M., Fullerton, M., Dilley, R., Funder, J.W. Mineralocorticoids, hypertension and cardiac fibrosis. J Clin Invest 1994, 93: 2578-83.
95. Brilia, C.G., Matsubara, L.S., Weber, K.T. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol 1993; 25: 563-75.
96. Brilla, C.G., Weber, K.T. Mineralocorticoid excess, dietary sodium and myocardial fibrosis. J Lab Clin Med 1992, 120: 893-901.
97. Doering, C.W., Jalil, J.E., Janicki, J.S. Collagen network remodeling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res 1988, 22: 686-95.
98. Hasenfus, G. Animal models of human cardiovascular disease, heart failure and hypertrophy. Cardiovasc Res 1998, 39: 60-76.
99. Brilla, C.G., Janicki, J.S., Weber, K.T. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991, 83: 1771-9.
100. Sen, S., Tarazi, R.C., Bumpus, F.M. Effect of converting enzyme inhibitor (SQ14,225) on myocardial hypertrophy in spontaneously hypertensive rats. Hypertension 1980, 2: 169-76.
101. Pahor, M., Bernabei, R., Sgadari, A., Gambassi, G. Jr., La Giuduce, PL., Pacifici, L., Ramacci, M.T., Lagiasta, C., Olivetti, G., Carbonin, P. Enalapril prevents cardiac fibrosis and arrhythmias in hypertensive rats. Hypertension 1991, 18: 148-57.
102. Brilla, C.G., Janicki, J.S., Weber, K.T. Impaired diastolic function and coronary reserve in genetic hypertension: Role of interstitial fibrosis and medial thickening of intramyocardial arteries. Circ Res 1991, 69: 107-15.
103. Brilla, C.G., Matsubara, L., Weber, K.T. Advanced hypertensive heart disease in spontaneously hypertensive rats. Hypertension 1996, 28: 269-75.
104. Panizio, A., Parolo, J., Hernandez, M., Galindo, M.F., Cenarruzabeitia, E., Diez, J. Quinapril decreases myocardial accumulation of extracellular matrix components in spontaneously hypertensive rats. Am J Hypertens 1995, 8: 815-22.
105. Yang, C.M., Kandaswamy, V., Young, D., Sen, S. Changes in collagen phenotypes during progression and regression of cardiac hypertrophy. Cardiovasc Res 1997, 36: 236-45.
106. Yu, H., Gallagher, A.M., Garfin, P.M., Printz, M.P. Prostacyclin release by rat cardiac fibroblasts. Inhibition of collagen expression. Hypertension 1997, 30: 1047-53.
107. Yonezawa, T., Unemoto, S., Fujii, A., Katayama, K., Matsuzahi, M. Comparative effects of type I angiotensin II-receptor blockade with angiotensin-converting-eniyme inhibitor on left ventricular distensibility and collagen metabolism in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1996, 27: 119-24.
108. 1-receptor antagonist on gene expression and the cellular phenotype. J Hypertens 1997, 15: S3-7.
109. Jalil, J.E., Janicki, J.S., Pick, R., Weber, K.T. Coronary vascular remodeling and myocardial fibrosis in the rat with renovascular hypertension. Response to captopril. Am J Hypertens 1991, 4: 51-5.
110. Michel, J.P., Dussaule, J.C., Choudat, L. Effects of antihypertensive treatment in one clip, two kidney hypertension in rats. Kidney Int 1986, 29: 1011-20.
111. Karam, H., Heudes, D., Hess, P., Gonzales, M.F., Löffler, B.M., Clozel, M., Clozel, J.P. Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats. Cardiovasc Res 1996, 31: 287-95.
112. Dusaillant, G.R., Gonzalez, H., Cespedes, C., Jalil, J.E. Regression of left ventricular hypertrophy in experimental renovascular hypertension: Diastolic dysfunction depends more on myocardial collagen than it does on myocardial mass. J Hypertens 1996, 14: 1117-23.
113. Lee, M.A., Böhm, M., Kim, S., Bachmann, S., Bachmann, J., Bader, M., Ganten, D. Differential gene expression of renin and angiotensinogen in the TGR (m Ren 2) 27 transgenic rat. Hypertension 1995, 25: 1570-80.
114. Witte, K., Schnecko, A., Voll, C., Schmidt, T., Lemmer, B. Effects of amlodipine once or twice daily on circadian blood pressure profile, myocardial hypertrophy and β-adrenergic signaling in transgenic hypertensive TGR (m Ren 2) 27 rats. J Cardiovasc Pharmacol 1998, 31: 661-8.
115. Ohta, K., Kim, S., Wanibuchi, H., Ganten, D., Iwao, H. Contribution of local renin-angiotensin system to cardiac hypertrophy, phenotypic modulation and remodeling in TGR (m Ren 2) 27 transgenic rats. Circulation 1996, 94: 785-91.
116. Böhm, M., Lippoldt, A., Wienen, W., Ganten, D., Bader, M. Reduction of cardiac hypertrophy in TGR (m Ren 2) 27 by angiotensin II receptor blockade. Mol Cell Biochem 1996, 163/164: 217-21.
117. Villareal, F.J., MacKenna, D.A., Omens, J.H., Dillmann, W.H. Myocardial remodeling in hypertensive Ren-2 transgenic rats. Hypertension 1995, 25: 98-104.
118. Van Krimpen, C., Smits, J.F.M., Cleutjens, J.P.M. DNA synthesis in the non-infarcted cardiac interstitium is increased after left coronary artery ligation in the rat: Effect of captopril. J Mol Cell Cardiol 1991, 23: 1245-53.
119. Michel, J.B., Lattion, A.L., Salzmann. J.L. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res 1988, 62: 641-50.
120. Schieffer, B., Winger, A., Meybrunn, M. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type I receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 1994, 89: 2273-82.
121. Smits, J.F.M., Van Krimpen, C., Schoemaker, R.G., Cleutjens, J.P.M., Daenen, M.J.A.P. Angiotensin II receptor blockade after myocardial infarction in rats: Effects on hemodynamics, myocardial DNA synthesis and interstitial collagen content. J Cardiovasc Pharmacol 1992, 20: 772-8.
122. Liu, Y.H., Yang, X.P., Sharov, V.G., Carretero, O.A. The role of angiotensin II type I receptor in the effect of chronic blockade of angiotensin II type I receptor on heart failure in rats. Hypertension 1996, 28: 512-8.
123. 1 receptor blockade on cardiac collagen remodeling after myocardial infarction. Cardiovasc Res 1997, 35: 223-32.
124. Hanatani, A., Yoshiyama, M., Kim, S. Inhibition by angiotensin II type receptor antagonist of cardiac phenotypic modulation after myocardial infarction. J Mol Cell Cardiol 1995, 27: 1905-14.
125. Taylor, K., Pallen, R.D., Smith, J.J., Aronovitz, M.J., Wight, J., Salomon, R.N., Konstam, M.A. Divergent effects of angiotensin-converting enzyme inhibition and angiotensin II receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats. J Cardiovasc Pharmacol 1998, 31: 654-60.
126. Ceiler, D.L., Marjorie, H.J., Nelissen-Vrancken, G., De Mey, J.G.R., Smiths, J.F.M. Effect of chronic blockade of angiotensin II receptor subtypes on aortic compliance in rats with myocardial infarction. J Cardiovasc Pharmacol 1998, 31: 630-7.
127. Grimm, D., Kromer, E.P., Böcker, W., Bruckschlegel, G., Holmer, S.R., Riegger, G.A.J., Schunkert, H. Regulation of extracellular matrix proteins in pressure-overload cardiac hypertrophy: Effects of angiotensin-converting enzyme inhibition. J Hypertens 1998, 16: 1345-55.
128. Schunkert, H., Weinberg, E.O., Bruckschlegel, G., Riegger, G.A.J., Lorell, B.H. Alteration of growth responses in established cardiac pressure-overload hypertrophy in rats with aortic banding. J Clin Invest 1995, 96: 2768-74.
129. Rossi, R., Peres, L.C. Effect of captopril on the prevention and regression of myocardial cell hypertrophy and interstitial fibrosis in pressure overload hypertrophy. Am Heart J 1992, 124: 700-9.
130. Watanabe, M., Kawaguchi, H., Onozuka, H., Mikami, T., Urasawa, K., Okamoto, H., Watanabe, S., Abe, K., Kitabatake, A. Chronic effects of enalapril and amlodipine in cardiac remodeling in cardiomyopathic hamster hearts. J Cardiovasc Pharmacol 1998, 32: 248-59.
131. Mansoor, A.M., Honda, M., Kuramochi, T., Tanaka, K., Morioka, S., Takabatake, T. Effect of ACE inhibition and β-blockade on collagen remodeling in the heart of Bio 14.6 hamsters. Clin Exp Pharmacol Physiol 1996, 23: 43-9.
132. Postlethwaite, A.E., Keski-Oja, J., Moses, H.L., Kang, A.H. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor-β. J Exp Med 1997, 165: 251-6.
133. Butt, R.P., Laurent, G.J., Bishop, J.E. Collagen production and replication by cardiac fibroblasts is enhanced in response to diverse classes of growth factors. Eur J Cell Biol 1995, 68: 330-5.
134. Eghbali, M., Tomek, R., Woods, C, Bhambi, B. Cardiac fibroblasts are predisposed to convert into myocyte phenotype: Specific effect of transforming growth factor-beta. Proc Natl Acad Sci USA 1991, 88: 795-9.